These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3042958)

  • 21. Antimicrobial activity of ceftriaxone: a review.
    Cleeland R; Squires E
    Am J Med; 1984 Oct; 77(4C):3-11. PubMed ID: 6093515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis.
    Scheld WM; Rocha H; Sande MA; Bryan JP
    Am J Med; 1984 Oct; 77(4C):42-9. PubMed ID: 6093518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
    Husson MO; Izard D; Leclerc H
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis.
    Fantin B; Pangon B; Potel G; Vallois JM; Caron F; Bure A; Carbon C
    Antimicrob Agents Chemother; 1989 May; 33(5):767-70. PubMed ID: 2665645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diffusion of cefotiam into ascitic fluid].
    Dao C; Hercelin B; Chotard Y; Veil N
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):527-9. PubMed ID: 3911148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefmenoxime therapy for gynecologic and obstetric infections.
    Rao B; Savage EW; Chuah SK; Bansal MB; Dhawan VK; Thadepalli H
    Obstet Gynecol; 1985 Sep; 66(3):377-83. PubMed ID: 3860790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):389-92. PubMed ID: 3907491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biliary elimination of cefotiam, an experimental and clinical study.
    Brogard JM; Arnaud JP; Blickle JF; Levy P; Dorner M; Lautier F
    Chemotherapy; 1986; 32(3):222-35. PubMed ID: 3458565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis.
    Contrepois A; Vallois JM; Garaud JJ; Pangon B; Mohler J; Meulemans A; Carbon C
    J Antimicrob Chemother; 1986 Feb; 17(2):227-37. PubMed ID: 3516963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of diclofenac on ceftriaxone pharmacokinetics in humans.
    Merle-Melet M; Bresler L; Lokiec F; Dopff C; Boissel P; Dureux JB
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2331-3. PubMed ID: 1444314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study on the relationship between pharmacokinetics and antibacterial activity: comparison between ceftriaxone and cefotaxime within the respiratory tract.
    Fraschini F; Scaglione F
    Chemotherapy; 1989; 35(2):77-82. PubMed ID: 2758870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime.
    Regamey C
    Chemotherapy; 1985; 31(2):85-94. PubMed ID: 3987394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of cefotiam administered intravenously and intramuscularly to healthy adults.
    Brisson AM; Bryskier A; Millerioux L; Fourtillan JB
    Antimicrob Agents Chemother; 1984 Oct; 26(4):513-8. PubMed ID: 6097166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis.
    Decazes JM; Ernst JD; Sande MA
    Antimicrob Agents Chemother; 1983 Oct; 24(4):463-7. PubMed ID: 6316841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of prophylactic intravenous ceftriaxone in maxillofacial surgery.
    Stoll P
    Chemotherapy; 1987; 33(4):291-6. PubMed ID: 3475196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-performance liquid chromatographic assay of cefotaxime, desacetylcefotaxime and ceftriaxone in rat plasma.
    Hakim L; Bourne DW; Triggs EJ
    J Chromatogr; 1988 Jan; 424(1):111-7. PubMed ID: 3366822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of cefotiam in normal humans.
    Daschner FD; Hemmer KA; Offermann P; Slanicka J
    Antimicrob Agents Chemother; 1982 Dec; 22(6):958-60. PubMed ID: 6297387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of cefotiam in humans.
    Rouan MC; Lecaillon JB; Guibert J; Modai J; Schoeller JP
    Antimicrob Agents Chemother; 1985 Feb; 27(2):177-80. PubMed ID: 3857018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of SCE-1141, a stereoisomer of cefmenoxime, in rats.
    Kita Y; Itakura K; Tsuchiya K; Imada A
    J Antimicrob Chemother; 1986 Feb; 17(2):205-13. PubMed ID: 3457784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic study of cefmenoxime (SCE 1365-CMX) in healthy adults.
    Fourtillan JB; Bryskier A; Mignot A; Borsa F; Humbert G
    Am J Med; 1984 Dec; 77(6A):28-31. PubMed ID: 6097120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.